NARDINI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.255
EU - Europa 3.097
AS - Asia 800
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 9
AF - Africa 7
OC - Oceania 4
Totale 8.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.237
IT - Italia 1.029
GB - Regno Unito 951
SE - Svezia 409
CN - Cina 313
DE - Germania 217
TR - Turchia 208
UA - Ucraina 163
SG - Singapore 142
FI - Finlandia 93
HK - Hong Kong 75
FR - Francia 69
BG - Bulgaria 63
IN - India 25
IR - Iran 21
IE - Irlanda 16
BE - Belgio 14
CA - Canada 13
EU - Europa 12
LT - Lituania 12
SI - Slovenia 11
CH - Svizzera 7
NL - Olanda 7
ES - Italia 6
PL - Polonia 6
BR - Brasile 5
RU - Federazione Russa 5
CO - Colombia 4
ID - Indonesia 4
MY - Malesia 4
AT - Austria 3
AU - Australia 3
RO - Romania 3
RS - Serbia 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CU - Cuba 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
MG - Madagascar 2
PA - Panama 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SM - San Marino 1
ZA - Sudafrica 1
Totale 8.186
Salva come PNG Salva come JPEG
Città #
Southend 832
Woodbridge 496
Fairfield 433
Chandler 429
Jacksonville 351
Ashburn 319
Ann Arbor 260
Houston 258
Nyköping 246
Dearborn 234
Wilmington 194
Seattle 168
Cambridge 150
Beijing 142
Izmir 120
Singapore 99
Milan 79
Hong Kong 74
Princeton 70
Rome 65
Sofia 62
Eugene 61
San Diego 61
Modena 47
Naples 38
Des Moines 37
Frankfurt am Main 37
Helsinki 35
New York 32
Shanghai 31
London 20
Philadelphia 20
Florence 18
Bologna 16
Dublin 16
Redwood City 16
San Mateo 15
Bari 14
Boardman 13
Brussels 13
Palermo 13
Turin 13
Brescia 12
Catania 12
Norwalk 12
Augusta 10
Falls Church 10
Guangzhou 10
Hefei 10
Los Angeles 10
Mashhad 10
Nanjing 10
Verona 10
Bremen 9
Grafing 9
Ottawa 9
Ardabil 8
Cosenza 8
Treviso 8
Bergamo 7
Kunming 7
Padova 7
Perugia 7
Pisa 7
Ferrara 6
Jinan 6
Parma 6
Piacenza 6
Rio Saliceto 6
Genoa 5
Indiana 5
Kraków 5
Legnano 5
Monmouth Junction 5
Saint-martin-du-tertre 5
Auburn Hills 4
Bangalore 4
Cascina 4
Chiswick 4
Crispano 4
Grantorto 4
Jakarta 4
Limbiate 4
Mumbai 4
Pescara 4
San Martino Siccomario 4
Torre del Greco 4
Amalfi 3
Belgrade 3
Borås 3
Carpi 3
Castenedolo 3
Cortemaggiore 3
Dresden 3
Hangzhou 3
Innsbruck 3
Macherio 3
Medellín 3
Montecatini Terme 3
Nanchang 3
Totale 5.996
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 984
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 202
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 195
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study. 189
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 173
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 172
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 171
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 168
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 162
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 155
Age-related comorbidities in people living with HIV 144
Detectable HIV viral load is associated with metabolic syndrome. 143
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 142
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 142
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 140
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 137
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 133
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 132
Virologic failure and metabolic syndrome in patients with HIV infection 129
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 126
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 125
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 125
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 123
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 122
Virologic failure and metabolic syndrome in patients with HIV infection 122
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 120
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 119
Severity of lipodystrophy is associated with decreased health-related quality of life 119
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 119
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 118
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 115
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 114
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 113
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 112
How do frailty mediate pathway leading to disability 110
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 108
Relapse of HIV-related buffalo hump after liposuction 108
Does lipodistrophy affect quality of life? 107
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 106
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 105
È possibile un counselling HIV su internet? 103
Validity of body image perception in women with HIV. 102
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 101
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 99
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 98
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 96
Body Image perception in HIV infected women with body fat redistribution. 95
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 95
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 94
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 90
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 90
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 88
Lipodystrophy and quality of life: a prospective study 88
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 87
Prevalence and risk factors of pubic lipomas in HIV-infected patients 85
HIV counselling looks for new target and methods web versus face to face counselling 84
Qual è il rapporto tra qualità di vita e lipodistrofia 82
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 82
HIV counselling and prevention on the WEB 81
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 77
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 77
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 74
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 41
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 36
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 13
Totale 8.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.311 0 0 35 92 148 218 264 217 114 44 103 76
2020/20211.215 100 43 103 118 182 71 109 131 82 118 95 63
2021/2022987 21 158 63 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/2025186 117 69 0 0 0 0 0 0 0 0 0 0
Totale 8.307